Jon Faiz Kayyem, Director at Inhibrx, Inc. (INBX), sold 19,000 shares at $30.58 ($573K) on 2022-10-21, disclosed to the SEC on 2022-10-24.
Open-market sale of $573k INBX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.39 | 3,572 | $105K | 18.3% |
| 2 | $29.39 | 3,572 | $105K | 18.3% |
| 3 | $30.58 | 5,928 | $181K | 31.7% |
| 4 | $30.58 | 5,928 | $181K | 31.7% |
| Total | $30.13 avg | 19,000 | $573K | 100% |
| Filing → |
| INBX | BUY | 2026-09-08 | $568K | — | Filing → |
| INBX | BUY | 2024-11-22 | $1.5M | — | Filing → |
| INBX | BUY | 2024-06-07 | $2.0M | — | Filing → |